All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • KC1086Phase 21 trial

    Beijing Konruns Pharmaceutical Co., Ltd. · HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

  • KeynatinibTL007Phase 21 trial

    Medolution Ltd. · Non-Small Cell Lung Cancer With EGFR Mutation, Brain Metastases

  • KH617Phase 21 trial

    Sichuan Honghe Biotechnology Co., Ltd. · Recurrent Glioblastoma

  • KHN922Phase 21 trial

    Chengdu Kanghong Biotech Co., Ltd. · Advanced Solid Tumors Cancer

  • KK2430Phase 21 trial

    Kyowa Kirin Co., Ltd. · Hematologic Neoplasms

  • KL590586Phase 21 trial

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumor

  • KN035Phase 21 trial

    3D Medicines (Sichuan) Co., Ltd. · Solid Tumor

  • KN713Phase 21 trial

    New Cancer Cure-Bio Co.,Ltd. · Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  • KQB198Phase 21 trial

    Kumquat Biosciences Inc. · GIST - Gastrointestinal Stromal Tumor, GIST, GIST Metastatic Cancer

  • KVA12123Phase 21 trial

    Kineta Inc. · Cancer, Solid Tumor, Melanoma

  • KY-0301Phase 21 trial

    Novatim Immune Therapeutics (Zhejiang) Co., Ltd. · Solid Tumors

  • LAT010Phase 21 trial

    Latticon Antibody Therapeutics, Inc · Advanced Solid Tumor

  • LBL-033Phase 21 trial

    Nanjing Leads Biolabs Co.,Ltd · Advanced Malignant Tumors

  • LCB02APhase 21 trial

    LigaChem Biosciences, Inc. · Advanced Solid Tumors

  • LCB84Phase 21 trial

    LigaChem Biosciences, Inc. · Advanced Solid Tumors

  • leronlimabPRO 140Phase 21 trial

    CytoDyn, Inc. · Metastatic Colorectal Cancer (mCRC)

  • Letetresgene autoleucellete-cel, GSK3377794Phase 21 trial

    USWM CT, LLC · Neoplasms

  • LEU011Phase 21 trial

    Leucid Bio · Tumor, Solid

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • LinrodostatBMS-986205Phase 21 trial

    Bristol Myers Squibb · Advanced Cancer

  • LM-2417Phase 21 trial

    LaNova Medicines Limited · Advanced Solid Tumor

  • LM-350Phase 21 trial

    LaNova Medicines Limited · Malignant Tumors

  • LM101Phase 21 trial

    LaNova Medicines Limited · Malignant Tumors

  • LP-184Phase 21 trial

    Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM

  • LPM6690176Phase 21 trial

    Luye Pharma Group Ltd. · Metastatic Colorectal Cancer (mCRC)

  • LSAM-CisplatinPhase 21 trial

    NanOlogy, LLC (doing business as Intryx Therapeutics, LLC) · Diffuse Midline Glioma (DMG), Diffuse Intrinsic Pontine Glioma (DIPG), Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma

  • LTT462Phase 21 trial

    Novartis · Melanoma

  • Lu-177-DGULPhase 21 trial

    Cellbion Co., Ltd. · Prostate Cancer, mCRPC

  • LUM015Phase 21 trial

    Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer

  • LY2784544Phase 21 trial

    Eli Lilly · Neoplasms, Hematologic

  • LY3537021Phase 21 trial

    Eli Lilly · Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions

  • LYL273Phase 21 trial

    Lyell Immunopharma, Inc. · Colorectal Cancer

  • LYT-200Phase 21 trial

    PureTech · Metastatic Cancer, Solid Tumor, Head and Neck Cancer

  • M6223Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

  • MDX2001Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer

  • MDX2004Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Advanced Tumors

  • MerestinibLY2801653Phase 21 trial

    Eli Lilly · Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer

  • MHB009CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor

  • MHB034CPhase 21 trial

    Minghui Pharmaceutical (Shanghai) LTD · Advanced Malignant Solid Tumor

  • MHB042CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor

  • MHB046CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Solid Cancer

  • MHB048CPhase 21 trial

    Minghui Pharmaceutical (Hangzhou) Ltd · mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor

  • MIT-001Phase 21 trial

    MitoImmune Therapeutics · Head and Neck Squamous Cell Carcinoma, Oral Mucositis

  • MIV-818Phase 21 trial

    Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases

  • MK-1200Phase 21 trial

    Merck & Co. · Advanced Solid Tumors

  • MK-2750Phase 21 trial

    Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm

  • ML-016iNPG-pDoxPhase 21 trial

    BrYet US, Inc. · Advanced Solid Tumor With Lung and/or Liver Involvement

  • MocaciclibQ901Phase 21 trial

    Qurient Co., Ltd. · Advanced Cancer, Metastatic Cancer

  • MPB-1734DMB025Phase 21 trial

    MegaPro Biomedical Co. Ltd. · Solid Tumor, Unspecified, Adult

NewerPage 21 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.